Accelerated TMS for MDD
RecruitingNCT07147218Phase: NAStarted 2025-08-21
Summary
An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).
Eligibility
Sex
ALL
Min Age
15 Years
Max Age
None
Locations
Brighter NeurotherapeuticsNew York, New York, United States
TMS of the CarolinasCharlotte, North Carolina, United States
New chapter TMSSpokane, Washington, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07147218